Koshy A. Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024. J Clin Exp Hepatol. 2025;15(1):102406.
Article CAS PubMed Google Scholar
Kornberg A, Seyfried N, Friess H. Clinically Evident Portal Hypertension Is an Independent Risk Factor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. J Clin Med. 2025; 14(6).
Akula V, Chen L, Acikgoz Y, Klein K, Yavuz BG, Cevik L, et al. Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma. NPJ Precis Oncol. 2025;9(1):60.
Article PubMed PubMed Central Google Scholar
Pamecha V, Tharun G, Patil NS, Mohapatra N, Kumar A, Thapar S, et al. Graft Inflow Modulation by Splenic Artery Ligation for Portal Hyperperfusion Does Not Decrease Rates of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: A Randomized Control Trial. Ann Surg. 2025;281(4):561–72.
Zhang XF, Niu XF, Li LX, He X, Li ZJ, Liu ZW, et al. Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy. Curr Med Res Opin. 2025;41(2):253–9.
Romero-Cristóbal M, Clemente-Sánchez A, Ramón E, Téllez L, Canales E, Ortega-Lobete O, et al. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2023;5(3):100645.
Chen J, Hu Z, Li H, Su R, Lin Z, Zhuo J, et al. Machine learning predicts post-transplant muscle loss in hepatocellular carcinoma patients without sarcopenia. BMC Cancer. 2025;25(1):1565.
Article CAS PubMed PubMed Central Google Scholar
Gao JP, Lu Z, Zhang J, Qin SD, Zhao JF, Huang JT et al. Clinically Related Factors of Liver Failure in Patients With Liver Cirrhosis After Hepatectomy. Surgical laparoscopy, endoscopy & percutaneous techniques. 2025; 35(4).
Nakajima T, Ikuta S, Aihara T, Ikuta L, Matsuki G, Fujikawa M, et al. Intraoperatively measured prehepatectomy portal vein pressure as a useful predictor of posthepatectomy liver failure. Langenbecks Arch Surg. 2024;409(1):314.
Tao H, Li B, Zeng X, Tang X, Zhang E, Li J et al. Artificial intelligence-based anatomy recognition in laparoscopic hepatectomy: multicentre study. Br J Surg. 2024; 111(10):znae254.
Liao K, Yang K, Cao L, Lu Y, Zheng B, Li X, et al. Laparoscopic anatomical versus non-anatomical hepatectomy in the treatment of hepatocellular carcinoma: a randomised controlled trial. International journal of surgery (London, England). 2022;102:106652.
Tian F, Cao L, Chen J, Zheng S, Li J. 3D laparoscopic anatomical hepatectomy guided by 2D real-time indocyanine green fluorescence imaging for hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2024;13(3):494–9.
Fukutomi S, Sakai H, Goto Y, Hashimoto K, Midorikawa R, Arai S, et al. Short- and Long-term Outcomes of Laparoscopic Versus Open Repeat Hepatectomy for Hepatocellular Carcinoma. Anticancer Res. 2025;45(8):3523–30.
Guo ZY, Hong Y, Tu B, Cheng Y, Wang XM. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: a propensity score-matched survival analysis. Hepatobiliary Pancreat Dis international: HBPD INT. 2023;22(4):358–65.
Shinkawa H, Kaibori M, Kabata D, Nakai T, Ueno M, Hokuto D, et al. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Surg Endosc. 2024;38(2):757–68.
Xia F, Zhang Q, Ndhlovu E, Zheng J, Yuan M, Gao H, et al. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study. Surg Endosc. 2024;38(2):799–812.
Xiang ZQ, Wu YC, Qu XL, Luo DJ, Liang H, Ameer S, et al. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis. World J Surg Oncol. 2024;22(1):3.
Article PubMed PubMed Central Google Scholar
Taha AMI, Temerik AR, Eweis MK, Sayed MM, Hassan RA. Splenic Artery Ligation Versus Splenectomy for Portal Inflow Modulation in Adult Living Donor Liver Transplant: Effects on Early Graft Function, A Prospective Study. Exp Clin Transplant. 2024; 22(10):794–9.
Subramaniyam R, Jamir I, Kumar N, Agrawal N, Sood G, Shriya A, et al. Implementation of intraoperative distal splenic artery ligation for portal inflow modulation in adult living donor liver transplantation. Liver Transpl. 2025;31(10):1238–49.
Carrapita J, Abrantes AM, Campelos S, Gonçalves AC, Cardoso D, Sarmento-Ribeiro AB, et al. Impact of splenic artery ligation after major hepatectomy on liver function, regeneration and viability. Sci Rep. 2016;6:34731.
Article CAS PubMed PubMed Central Google Scholar
Yazici SE, Atasever A, Yuzer Y. Splenic artery ligation: effects on portal flow and hypersplenism in living donor liver transplantation. Ann Transplant. 2025;30:e947760.
Article PubMed PubMed Central Google Scholar
Wang Z, Qu Z, Mu F, Xu L, Hu L, Wang B, et al. Simultaneous splenic artery ligation during adult orthotopic liver transplantation improves surgical outcomes. World J Surg. 2025;49(10):2909–20.
Bashir S, Gupta S, Agarwal S, Saigal S. Successful embolization of spleen through gastroepiploic artery in a liver transplant recipient with splenic artery ligation. J Clin experimental Hepatol. 2022;12(2):645–8.
Junrungsee S, Vipudhamorn W, Lapisatepun W, Thepbunchonchai A, Chotirosniramit A, Lapisatepun W, et al. Portal flow modulation by splenic artery ligation to prevent posthepatectomy liver failure: a randomized controlled trial. Surgery. 2025;185:109351.
Theodoraki K, Vezakis A, Massaras D, Louta A, Arkadopoulos N, Smyrniotis V. Splenic Artery Ligation: An Ontable Bail-Out Strategy for Small-for-Size Remnants after Major Hepatectomy: A Retrospective Study. J personalized Med. 2022; 12(10):1687.
Comments (0)